Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267397 · ClinicalTrials.gov registry record
Prevalence and Clinical Spectrum of the 22q11 Deletion
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
NCT00267397: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00267397 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00267397 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
Study Summary
The purpose of this project is to conduct population based surveillance for prenatally diagnosed congenital defects amount residents of the five counties to: improve the comprehensiveness of the Metropolitan Atlanta Congenital Defects Program (MACDP) to (1) better fulfill its objectives (2) allow assessment of the impact of prenatal diagnosis and elective termination on the birth prevalence of congenital defects in Atlanta (3) develop a registry of prenatally diagnosed defects to be used in epidemiologic and genetic studies, in evaluation prevention programs and in monitoring prenatal diagnostic technology.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1967-01 |
| Est. Completion | 2006-12 |
Why NCT00267397 stopped before completion
NCT00267397 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00267397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00267397 about?
NCT00267397 is a clinical study titled "Prevalence and Clinical Spectrum of the 22q11 Deletion". The purpose of this project is to conduct population based surveillance for prenatally diagnosed congenital defects amount residents of the five counties to: improve the comprehensiveness of the Metropolitan Atlanta Congenital Defects Program (MACDP) to (1) better fulfill its objectives (2) allow as...
What is the current status of trial NCT00267397?
This trial is currently terminated. The study started on 1967-01. Estimated completion is 2006-12.
Who is sponsoring clinical trial NCT00267397?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia